Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $10.43 USD
Change Today +0.14 / 1.36%
Volume 34.5K
AKBA On Other Exchanges
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Randall K. Johnson Ph.D.

Member of the Scientific Advisory Board, Akebia Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 86 board members in 9 different organizations across 12 different industries.

See Board Relationships


Dr. Randall K. Johnson, Ph.D., has been a Director of Callisto Pharmaceuticals Inc. since February 14, 2005. He serves as a Member of Scientific Advisory Board of MerLion Pharmaceuticals Pte Ltd., Akebia Therapeutics, Inc., TetraLogic Pharmaceuticals, Inc. (formerly, Gentara Corporation), Piramed Limited, Sapphire Therapeutics Inc., Progen Pharmaceuticals Inc. and S*BIO Pte Ltd. He serves as a Member of Scientific Advisory Board at Aerpio Therapeutics, Inc. He has been ...

Read Full Background

Corporate Headquarters*

245 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-871-2098
Fax: 617-871-2099

Board Members Memberships*

Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Special Project Committee
Former Director


BS 1968
University of Minnesota
PhD 1972
George Washington University
Post-Doctoral Training
Institut National Du Cancer

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AKBA:US $10.43 USD +0.14


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AKEBIA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at